Back to Results

InnovAge Holding Corp (INNV)

Featured in Overvalued Stocks Low-Float Small-Cap Momentum Stocks High-Growth Small-Cap Stocks Small-Cap Stocks

InnovAge Holding Corp (NASDAQ-INNV) is a NASDAQ-listed company in the healthcare providers and services industry. The security is common stock, and its security context is common equity. InnovAge focuses on organized care and support services for older adults who need help coordinating medical treatment, day-to-day assistance, and related health needs. Its business is centered on a care model that combines clinical services, personal support, and community-based care delivery. As a listed equity, the shares represent ownership in the company rather than a fund, note, or other instrument.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-INNV
$9.26
-20.6% Downside
Overvalued
$7
-40.0% Downside
Overvalued
Great
—
—
—
0.0%
September 15, 2026
-133.4x
6.8x
1.6x
1.504 B
1.533 B
5.8%
15.7%
5.2
—
-366.6%
Valuation • Fair Value

InnovAge Holding Corp (NASDAQ-INNV) Fair Value by Valuation Model

Compare the primary fair value estimate for InnovAge Holding Corp (NASDAQ-INNV) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$9.26

Estimated downside of 20.6% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$9.79

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$7.57

Earnings power value estimate.

Comps Fair Value

$9

Comparable-company valuation reference.

Analyst Price Target

$7

Analysts imply downside of 40.0%.

How to read these valuation models

Use this section to compare the primary fair value estimate for InnovAge Holding Corp (NASDAQ-INNV) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for InnovAge Holding Corp (NASDAQ-INNV)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

949.2 M

Current operating scale indicator.

Revenue Forecast

962.1 M

Forward revenue estimate.

EBITDA

23.826 M

Current operating profitability reference.

EBITDA Forecast

88.3 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review InnovAge Holding Corp (NASDAQ-INNV) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for InnovAge Holding Corp (NASDAQ-INNV)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-3.24

No elevated caution signal from this screen.

Altman Z-Score

5.2

Relatively strong balance-sheet zone.

FCF / Net Income

-366.6%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for InnovAge Holding Corp (NASDAQ-INNV). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for InnovAge Holding Corp (NASDAQ-INNV)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

September 15, 2026

Days to Earnings

56

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for InnovAge Holding Corp (NASDAQ-INNV), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

InnovAge Holding Corp (NASDAQ-INNV) Stock Forecast & Technical Outlook

Review InnovAge Holding Corp (NASDAQ-INNV) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for InnovAge Holding Corp (NASDAQ-INNV) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for InnovAge Holding Corp (NASDAQ-INNV) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for InnovAge Holding Corp (NASDAQ-INNV) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for InnovAge Holding Corp (NASDAQ-INNV) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for InnovAge Holding Corp (NASDAQ-INNV) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for InnovAge Holding Corp (NASDAQ-INNV)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, InnovAge Holding Corp (NASDAQ-INNV) has a Hold consensus, with 0 buy, 2 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 2
Sell 0
FAQ • Fast Investor Answers

InnovAge Holding Corp (NASDAQ-INNV) Stock FAQ

Quick answers about InnovAge Holding Corp (NASDAQ-INNV) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$9.26
Estimated downside 20.6%
Valuation Rating
Overvalued
Estimated downside of 20.6%
Analyst Target
$7
Implied downside 40.0%
Financial Health
Great
Current financial-health read

The current fair value estimate for InnovAge Holding Corp (NASDAQ-INNV) is $9.26. This implies an estimated downside of 20.6% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 20.6% versus the current market price.

The available analyst price target for InnovAge Holding Corp (NASDAQ-INNV) is $7. The analyst target implies estimated downside of 40.0%.

The current financial health read for InnovAge Holding Corp (NASDAQ-INNV) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for InnovAge Holding Corp (NASDAQ-INNV) is September 15, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for InnovAge Holding Corp (NASDAQ-INNV) is -133.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for InnovAge Holding Corp is 1.504 B.

The current enterprise value listed for InnovAge Holding Corp is 1.533 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for InnovAge Holding Corp is NASDAQ-INNV, and the stock is listed on NASDAQ.

InnovAge Holding Corp (NASDAQ-INNV) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for InnovAge Holding Corp is 5.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for InnovAge Holding Corp is 15.7%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks on NASDAQ View more

Guardant Health Inc (GH) Guardant Health Inc (GH)
Brightspring Health Services Inc (BTSG) Brightspring Health Services Inc (BTSG)
Brightspring Health Services Inc Unit (BTSGU) Brightspring Health Services Inc Unit (BTSGU)
The Ensign Group Inc (ENSG) The Ensign Group Inc (ENSG)
Henry Schein Inc (HSIC) Henry Schein Inc (HSIC)
Healthequity Inc (HQY) Healthequity Inc (HQY)
RadNet Inc (RDNT) RadNet Inc (RDNT)
Lifestance Health Group Inc (LFST) Lifestance Health Group Inc (LFST)
Alignment Healthcare LLC (ALHC) Alignment Healthcare LLC (ALHC)
Option Care Health Inc (OPCH) Option Care Health Inc (OPCH)
Privia Health Group Inc (PRVA) Privia Health Group Inc (PRVA)
Acadia Healthcare Company Inc (ACHC) Acadia Healthcare Company Inc (ACHC)
CorVel Corp (CRVL) CorVel Corp (CRVL)
Progyny Inc (PGNY) Progyny Inc (PGNY)
Clover Health Investments Corp (CLOV) Clover Health Investments Corp (CLOV)
Aveanna Healthcare Holdings Inc (AVAH) Aveanna Healthcare Holdings Inc (AVAH)
Surgery Partners Inc (SGRY) Surgery Partners Inc (SGRY)
Addus HomeCare Corporation (ADUS) Addus HomeCare Corporation (ADUS)
Astrana Health Inc (ASTH) Astrana Health Inc (ASTH)
NeoGenomics Inc (NEO) NeoGenomics Inc (NEO)
GeneDx Holdings Corp (WGS) GeneDx Holdings Corp (WGS)
Adapthealth Corp (AHCO) Adapthealth Corp (AHCO)
Pennant Group Inc (PNTG) Pennant Group Inc (PNTG)
Omada Health Inc (OMDA) Omada Health Inc (OMDA)